Indication
Treatment of primary apnoea of premature newborns.
Official EMA Resources
View on EMA (ema.europa.eu)AI Drug & Interaction Analysis
Loading your page…
Loading your page…
Apnea
Marketing Authorisation Holder: Gennisium Pharma
EMA Authorisation: 19/08/2020
INN: caffeine citrate
AI Drug & Interaction Analysis
Free account required
Ask Osler about Gencebok: drug interactions and guideline evidence, with every claim numbered to its source. For reference and learning, not treatment advice.
Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.